Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

What can we learn from Europe?

¹Department of Medicine, Sahlgrenska University Hospital/Ostra, Göteborg, Sweden. karl.swedberg@hjl.gu.se

Heart (British Cardiac Society)

|April 16, 2005

Summary

European guidelines offer strong recommendations for secondary prevention after myocardial infarction. However, evidence-based therapies like beta blockers are underused across Europe, necessitating improved dissemination strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Candesartan in Heart Failure - Assessment of Reduction in Mortality and Morbidity (CHARM) Study Programme.

Blood pressure·2017

Same author

Prognostic significance of anaemia in patients with heart failure with preserved and reduced ejection fraction: results from the MAGGIC individual patient data meta-analysis.

QJM : monthly journal of the Association of Physicians·2015

Same author

Trends in mortality after first hospitalization with atrial fibrillation diagnosis in Sweden 1987 to 2006.

International journal of cardiology·2014

Same author

Clinical profiles and outcomes in patients with chronic heart failure and chronic obstructive pulmonary disease: an efficacy and safety analysis of SHIFT study.

International journal of cardiology·2013

Same author

The obesity paradox in heart failure patients with preserved versus reduced ejection fraction: a meta-analysis of individual patient data.

International journal of obesity (2005)·2013

Same author

Effect of nesiritide in patients with acute decompensated heart failure.

The New England journal of medicine·2011

Area of Science:

Cardiology
Public Health

Background:

European Society of Cardiology guidelines provide evidence-based recommendations for managing acute myocardial infarction and chronic heart failure.
Secondary prevention of complications post-myocardial infarction is crucial, with heart failure and left ventricular systolic dysfunction identified as key risk factors.

Purpose of the Study:

To evaluate the utilization of secondary prevention treatments across Europe following myocardial infarction.
To identify variations in treatment use among European countries and assess the underutilization of evidence-based therapies.

Main Methods:

Analysis of survey data evaluating the use of secondary prevention treatments in European countries.
Review of specific initiatives aimed at disseminating evidence-based secondary prevention strategies.

Main Results:

Significant variation exists in the use of secondary prevention treatments across European nations.
Evidence-based therapies, including beta blockers and angiotensin converting enzyme inhibitors, are generally underutilized.

Conclusions:

Despite clear guidelines, the adoption of evidence-based secondary prevention post-myocardial infarction in Europe remains suboptimal.
Successful dissemination strategies, exemplified by the Italian BRING-UP collaboration and the Swedish RIKS-HIA registry, can improve the utilization of critical treatments like beta blockers.

Related Experiment Videos